Cat. No. | Product name | CAS No. |
DC11056 |
Baloxavir marboxil
Featured
Baloxavir marboxil is a prodrug of S-033447. S-033447 is a small molecule inhibitor of the cap-dependent endonuclease of influenza A and B viruses. |
1985606-14-1 |
DC9486 |
Nucleozin
Featured
Nucleozin targets influenza A nucleoprotein (NP), a multifunctional, RNA-binding protein necessary for virus replication. |
341001-38-5 |
DCAPI1594 |
Oseltamivir phosphate
Featured
OSELTAMIVIR is an active (orally) inhibitor of the influenze virus neuraminidase and converted to the active acid metabolite in vivo. |
204255-11-8 |
DCAPI1121 |
Peramivir
Peramivir |
229614-55-5 |
DCAPI1010 |
Peramivir Trihydrate
Featured
Peramivir, also known as BCX1812 and RWJ 270201, is an antiviral drug for the treatment of influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. Peramivir was approved to treat influenza infection in adults. |
1041434-82-5 |
DC9815 |
Pimodivir(VX-787)
Featured
Pimodivir(VX-787) is a novel inhibitor of influenza virus replication that blocks the PB2 cap-snatching activity of the influenza viral polymerase complex. |
1629869-44-8 |
DC5105 |
Favipiravir (T-705)
Featured
T 705(Favipiravir) is a RNA-directed RNA polymerase NS5B inhibitor.T 705(Favipiravir) is useful for Antiviral agents. |
259793-96-9 |
DC8429 |
Verdinexor (KPT-335)
Featured
Verdinexor (KPT-335) is an orally bioavailable, selective XPO1/CRM1 inhibitor. |
1392136-43-4 |
DCAPI1063 |
Zanamivir (Relenza)
Featured
Zanamivir is an influenza viral neuraminidase inhibitor with IC50 values of 0.95 nM and 2.7 nM for influenza A and B, respectively. |
139110-80-8 |